Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 May;61(5):727–731. doi: 10.1038/bjc.1990.163

Production of immunoreactive insulin-like growth factor-I (IGF-I) and IGF-I binding proteins by human lung tumours.

J G Reeve 1, J A Payne 1, N M Bleehen 1
PMCID: PMC1971604  PMID: 1692471

Abstract

The production of insulin-like growth factor I (IGF-I) and IGF-I binding proteins (BPs) by human lung tumour cell lines in vitro has been examined and the levels of these substances in the serum of lung cancer patients investigated. While small cell lung cancer (SCLC) cell lines secreted both IGF-I and BPs, non-small cell lung cancer (NSCLC) cell lines secreted BPs only. No evidence of increased serum IGF-I levels was obtained in a cohort of 52 lung cancer patients having SCLC and NSCLC histologies. In contrast, serum levels of low molecular weight BPs were markedly elevated in the majority of lung cancer patients.

Full text

PDF
727

Images in this article

728Figure 1
on p.728
729Figure 2
on p.729
729Figure 3
on p.729

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baillie-Johnson H., Twentyman P. R., Fox N. E., Walls G. A., Workman P., Watson J. V., Johnson N., Reeve J. G., Bleehen N. M. Establishment and characterisation of cell lines from patients with lung cancer (predominantly small cell carcinoma). Br J Cancer. 1985 Oct;52(4):495–504. doi: 10.1038/bjc.1985.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baxter R. C., Martin J. L. Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog Growth Factor Res. 1989;1(1):49–68. doi: 10.1016/0955-2235(89)90041-0. [DOI] [PubMed] [Google Scholar]
  3. Baxter R. C., Martin J. L., Wood M. H. Two immunoreactive binding proteins for insulin-like growth factors in human amniotic fluid: relationship to fetal maturity. J Clin Endocrinol Metab. 1987 Sep;65(3):423–431. doi: 10.1210/jcem-65-3-423. [DOI] [PubMed] [Google Scholar]
  4. Baxter R. C. The somatomedins: insulin-like growth factors. Adv Clin Chem. 1986;25:49–115. doi: 10.1016/s0065-2423(08)60124-9. [DOI] [PubMed] [Google Scholar]
  5. Bell S. C., Keyte J. W. N-terminal amino acid sequence of human pregnancy-associated endometrial alpha 1-globulin, an endometrial insulin-like growth factor (IGF) binding protein--evidence for two small molecular weight IGF binding proteins. Endocrinology. 1988 Aug;123(2):1202–1204. doi: 10.1210/endo-123-2-1202. [DOI] [PubMed] [Google Scholar]
  6. Binkert C., Landwehr J., Mary J. L., Schwander J., Heinrich G. Cloning, sequence analysis and expression of a cDNA encoding a novel insulin-like growth factor binding protein (IGFBP-2). EMBO J. 1989 Sep;8(9):2497–2502. doi: 10.1002/j.1460-2075.1989.tb08386.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brinkman A., Groffen C., Kortleve D. J., Geurts van Kessel A., Drop S. L. Isolation and characterization of a cDNA encoding the low molecular weight insulin-like growth factor binding protein (IBP-1). EMBO J. 1988 Aug;7(8):2417–2423. doi: 10.1002/j.1460-2075.1988.tb03087.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Clemmons D. R., Elgin R. G., Han V. K., Casella S. J., D'Ercole A. J., Van Wyk J. J. Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/insulinlike growth factor I. J Clin Invest. 1986 May;77(5):1548–1556. doi: 10.1172/JCI112470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cohen K. L., Nissley S. P. The serum half-life of somatomedin activity: evidence for growth hormone dependence. Acta Endocrinol (Copenh) 1976 Oct;83(2):243–258. doi: 10.1530/acta.0.0830243. [DOI] [PubMed] [Google Scholar]
  10. Daughaday W. H., Mariz I. K., Blethen S. L. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J Clin Endocrinol Metab. 1980 Oct;51(4):781–788. doi: 10.1210/jcem-51-4-781. [DOI] [PubMed] [Google Scholar]
  11. Elgin R. G., Busby W. H., Jr, Clemmons D. R. An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci U S A. 1987 May;84(10):3254–3258. doi: 10.1073/pnas.84.10.3254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Furlanetto R. W., Marino J. M. Radioimmunoassay of somatomedin C/insulin-like growth factor I. Methods Enzymol. 1987;146:216–226. doi: 10.1016/s0076-6879(87)46023-0. [DOI] [PubMed] [Google Scholar]
  13. Hall K., Lundin G., Póvoa G. Serum levels of the low molecular weight form of insulin-like growth factor binding protein in healthy subjects and patients with growth hormone deficiency, acromegaly and anorexia nervosa. Acta Endocrinol (Copenh) 1988 Jul;118(3):321–326. doi: 10.1530/acta.0.1180321. [DOI] [PubMed] [Google Scholar]
  14. Hardouin S., Hossenlopp P., Segovia B., Seurin D., Portolan G., Lassarre C., Binoux M. Heterogeneity of insulin-like growth factor binding proteins and relationships between structure and affinity. 1. Circulating forms in man. Eur J Biochem. 1987 Dec 30;170(1-2):121–132. doi: 10.1111/j.1432-1033.1987.tb13676.x. [DOI] [PubMed] [Google Scholar]
  15. Hintz R. L., Liu F., Rosenfeld R. G., Kemp S. F. Plasma somatomedin-binding proteins in hypopituitarism: changes during growth hormone therapy. J Clin Endocrinol Metab. 1981 Jul;53(1):100–104. doi: 10.1210/jcem-53-1-100. [DOI] [PubMed] [Google Scholar]
  16. Jaques G., Rotsch M., Wegmann C., Worsch U., Maasberg M., Havemann K. Production of immunoreactive insulin-like growth factor I and response to exogenous IGF-I in small cell lung cancer cell lines. Exp Cell Res. 1988 Jun;176(2):336–343. doi: 10.1016/0014-4827(88)90335-7. [DOI] [PubMed] [Google Scholar]
  17. Knauer D. J., Smith G. L. Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7252–7256. doi: 10.1073/pnas.77.12.7252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Koistinen R., Kalkkinen N., Huhtala M. L., Seppälä M., Bohn H., Rutanen E. M. Placental protein 12 is a decidual protein that binds somatomedin and has an identical N-terminal amino acid sequence with somatomedin-binding protein from human amniotic fluid. Endocrinology. 1986 Apr;118(4):1375–1378. doi: 10.1210/endo-118-4-1375. [DOI] [PubMed] [Google Scholar]
  19. Lee Y. L., Hintz R. L., James P. M., Lee P. D., Shively J. E., Powell D. R. Insulin-like growth factor (IGF) binding protein complementary deoxyribonucleic acid from human HEP G2 hepatoma cells: predicted protein sequence suggests an IGF binding domain different from those of the IGF-I and IGF-II receptors. Mol Endocrinol. 1988 May;2(5):404–411. doi: 10.1210/mend-2-5-404. [DOI] [PubMed] [Google Scholar]
  20. Macaulay V. M., Teale J. D., Everard M. J., Joshi G. P., Millar J. L., Smith I. E. Serum insulin-like growth factor-I levels in patients with small cell lung cancer. Eur J Cancer Clin Oncol. 1988 Jul;24(7):1241–1242. doi: 10.1016/0277-5379(88)90135-6. [DOI] [PubMed] [Google Scholar]
  21. Minuto F., Del Monte P., Barreca A., Fortini P., Cariola G., Catrambone G., Giordano G. Evidence for an increased somatomedin-C/insulin-like growth factor I content in primary human lung tumors. Cancer Res. 1986 Feb;46(2):985–988. [PubMed] [Google Scholar]
  22. Pert C. B., Schumacher U. K. Plasma bombesin concentrations in patients with extensive small cell carcinoma of the lung. Lancet. 1982 Feb 27;1(8270):509–509. doi: 10.1016/s0140-6736(82)91478-7. [DOI] [PubMed] [Google Scholar]
  23. Rinderknecht E., Humbel R. E. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem. 1978 Apr 25;253(8):2769–2776. [PubMed] [Google Scholar]
  24. Smith G. L. Somatomedin carrier proteins. Mol Cell Endocrinol. 1984 Feb;34(2):83–89. doi: 10.1016/0303-7207(84)90058-3. [DOI] [PubMed] [Google Scholar]
  25. Wilkins J. R., D'Ercole A. J. Affinity-labeled plasma somatomedin-C/insulinlike growth factor I binding proteins. Evidence of growth hormone dependence and subunit structure. J Clin Invest. 1985 Apr;75(4):1350–1358. doi: 10.1172/JCI111836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Zapf J., Schoenle E., Jagars G., Sand I., Grunwald J., Froesch E. R. Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein. J Clin Invest. 1979 May;63(5):1077–1084. doi: 10.1172/JCI109377. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES